RESEARCH PAPER
The occurrence and quality of care of non-communicable diseases in people living with HIV in Maseru, Lesotho: a mixed-methods study
 
More details
Hide details
 
Submission date: 2016-10-10
 
 
Final revision date: 2017-01-29
 
 
Acceptance date: 2017-02-11
 
 
Publication date: 2017-05-25
 
 
HIV & AIDS Review 2017;16(3):155-162
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Chronic non-communicable diseases (NCDs) constitute a health problem worldwide. This problem is particularly important in people living with human immunodeficiency virus (PLHIV) in sub-Saharan countries where the prevalence of NCDs is expected to increase due to the epidemio­logical transition of life spans for PLHIV as treatment outcomes for HIV continue to improve. This study is the first to assess the occurrence and quality of care (QoC) of NCDs in PLHIV and to identify the contextual issues underpinning the QoC in Lesotho – a sub-Saharan country with the second highest prevalence of HIV globally.
Material and methods: Based on the Donabedian (2005) model for assessing QoC, the study used a trian­gulation of quantitative patient responses on QoC of NCDs, their treatment outcomes and qualitative interviews with hospital staff in Maseru, Lesotho.
Results: Two hundred and forty-six PLHIV with a median survival time of 7 years since the first diagnosis of HIV (IQR: 3-9 years) and 25 hospital staff were included in the study. Forty-two percent (42%) of the patients had at least one diagnosed NCD, and 33% of these were diagnosed outside of the antiretroviral treatment (ART) centers. Overall, the QoC of NCDs was inadequate. Only 32% of patients with NCDs had records on NCD treatment outcomes in the ART centers. Shortage and disrepair of equipment, along with inadequate staff were the major barriers affecting the orga­nizational structure for the care of NCDs. Inadequate screening for NCDs, disintegrated checkup schedules for NCDs/HIV co-morbid conditions, and inadequate patient education were the major issues affecting the treatment processes.
Conclusions: The longer life spans of PLHIV in this study emphasises the need to scale up the diagnosis of NCDs while improving their QoC in PLHIV in Lesotho. The issues underpinning the QoC of NCDs should thus be prioritised in the interventions aimed at improving QoC of NCDs in PLHIV.
REFERENCES (32)
1.
Alwan A; World Health Organization. Global status report on noncommunicable diseases 2010. World Health Organization, Geneva 2011.
 
2.
WHO. A global brief on hypertension: silent killer, global public health crisis. World Health Organization, Geneva 2016.
 
3.
Longo D, Fauci A, Kasper D, et al. Harrison’s Principles of Internal Medicine. 18th ed. McGraw-Hill Professional, 2011.
 
4.
Schmidt MI, Duncan BB, Azevedo e Silva G, et al. Chronic non- communicable diseases in Brazil: burden and current challenges. Lancet 2011; 377: 1949-1961.
 
5.
Van Olmen J, Schellevis F, van Damme W, et al. Management of chronic diseases in sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. J Trop Med 2012; 2012: 349312.
 
6.
Janssens B, van Damme W, Raleigh B, et al. Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bull World Health Organ 2007; 85: 880-885.
 
7.
Mayosi BM, Flisher AJ, Lalloo UG, et al. The burden of non-communicable diseases in South Africa. Lancet 2009; 374: 934-947.
 
8.
Mugomeri E, Ramathebane MV, Maja L, et al. Knowledge of disease condition and medications among hypertension patients in Lesotho. J Am Soc Hypertens 2016; 10: 41-46.
 
9.
Donabedian A. Evaluating the Quality of Medical Care. Milbank Q 2005; 83: 691-729.
 
10.
Nutbeam D. The evolving concept of health literacy. Soc Sci Med 2008; 67: 2072-2078.
 
11.
Kruk ME, Nigenda G, Knaul FM. Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health 2015; 105: 431-437.
 
12.
Almeida RF, Vieira AP. Evaluation of HIV/AIDS patients’ knowledge on antiretroviral drugs. Braz J Infect Dis 2009; 13: 183-190.
 
13.
WHO. Lesotho factsheets of health statistics. Regional office for Africa: World Health Organisation. 2014. Available at: http://www.aho.afro.who.int/pr... (accessed 20.06.2015).
 
14.
Government of Lesotho. Lesotho – Demographic and Health Survey 2009. Ministry of Health and Social Welfare, Maseru 2009/2010.
 
15.
Government of Lesotho. Lesotho – Demographic and Health Survey 2011. Ministry of Health and Social Welfare, Maseru 2011.
 
16.
Government of Lesotho. Health research agenda for Lesotho (2013-2018). Available at: http://www.health.gov.ls/publi... (access­ed 14.06.2016).
 
17.
Cohen R, Lynch S, Bygrave H, et al. Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. J Int AIDS Soc 2009; 12: 23.
 
18.
Government of Lesotho. Lesotho global aids response report 2015. Available at: http://www.unaids.org/sites/de... (accessed 14.06.2016).
 
19.
Creswell JW. Research design: Qualitative, quantitative, and mixed methods approaches. SAGE Publications, Inc., 2013.
 
20.
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ 2011; 2: 53-55.
 
21.
Govindasamy D, Kranzer K, van Schaik N, et al. Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. PLoS One 2013; 8: e80017.
 
22.
Mateen FJ, Kanters S, Kalyesubula R, et al. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens 2013; 31: 1372-1378.
 
23.
Rabkin M, El-Sadr WM. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Global Public Health 2011; 6: 247-256.
 
24.
Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 2006; 20: 1019-1026.
 
25.
Fourie CMT, Van Rooyen JM, Kruger A, et al. Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population. Lipids 2010; 45: 73-80.
 
26.
Garg H, Joshi A, Mukherjee D. Cardiovascular complications of HIV infection and treatment. Cardiovasc Hematol Agents Med Chem 2013; 11: 58-66.
 
27.
Thinyane KH, Mothebe T, Sooro M, et al. An observational study of hypertension treatment and patient outcomes in a primary care setting. Pan Afr Med J 2015; 20: 424.
 
28.
Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165: 1179-1184.
 
29.
De-Graft Aikins A, Kushitor M, Koram K, et al. Chronic non-communicable diseases and the challenge of universal health coverage: insights from community-based cardiovascular disease research in urban poor communities in Accra, Ghana. BMC Public Health 2014; 14 (Suppl 2): S3.
 
30.
Mendis S, Abegunde D, Oladapo O, et al. Barriers to management of cardiovascular risk in a low-resource setting using hypertension as an entry point. J Hypertens 2004; 22: 59-64.
 
31.
Kilic M, Uzunçakmak T, Ede H. The effect of knowledge about hypertension on the control of high blood pressure. International Journal of the Cardiovascular Academy 2016; 2: 27-32.
 
32.
Rabkin M, Melaku Z, Bruce K, et al. Strengthening health systems for chronic care: leveraging HIV programs to support diabetes services in Ethiopia and Swaziland. J Trop Med 2012; 2012: 137460.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top